FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2854404943> ?p ?o ?g. }

• W2854404943 endingPage "67" @default.
• W2854404943 startingPage "57" @default.
• W2854404943 abstract "The New World alphaviruses –Venezuelan, eastern, and western equine encephalitis viruses (VEEV, EEEV, and WEEV respectively) – cause a febrile disease that is often lethal in equines and children and leads to long-term neurological sequelae in survivors. Endemic to the Americas, epizootic outbreaks of the three viruses occur sporadically in the continental United States. All three viruses aerosolize readily, replicate to high titers in cell culture, and have low infectious doses. Additionally, there are no FDA-approved vaccines or therapeutics for human use. To address the therapeutic gap, a high throughput assay utilizing a luciferase reporter virus, TC83-luc, was performed to screen a library of commercially available, FDA-approved drugs for antiviral activity. From a group of twenty compounds found to significantly decrease luminescence, the carcinoma therapeutic sorafenib inhibited replication of VEEV-TC83 and TrD in vitro. Additionally, sorafenib inhibited replication of EEEV and two Old World alphaviruses, Sindbis virus and chikungunya virus, at 8 and 16 h post-infection. Sorafenib caused no toxicity in Vero cells, and coupled with a low EC50 value, yielded a selectivity index of >19. Mechanism of actions studies suggest that sorafenib inhibited viral translation through dephosphorylation of several key proteins, including eIF4E and p70S6K, leading to a reduction in viral protein production and overall viral replication." @default.
• W2854404943 created "2018-07-19" @default.
• W2854404943 creator A5002035180 @default.
• W2854404943 creator A5003932349 @default.
• W2854404943 creator A5023118175 @default.
• W2854404943 creator A5051878224 @default.
• W2854404943 creator A5055970298 @default.
• W2854404943 creator A5078271785 @default.
• W2854404943 creator A5083661191 @default.
• W2854404943 creator A5085179199 @default.
• W2854404943 date "2018-09-01" @default.
• W2854404943 modified "2023-10-11" @default.
• W2854404943 title "Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses" @default.
• W2854404943 cites W1550916454 @default.
• W2854404943 cites W1608233475 @default.
• W2854404943 cites W1626240090 @default.
• W2854404943 cites W1626349769 @default.
• W2854404943 cites W1698641492 @default.
• W2854404943 cites W1855484651 @default.
• W2854404943 cites W1921832335 @default.
• W2854404943 cites W1967590733 @default.
• W2854404943 cites W1970605491 @default.
• W2854404943 cites W1971745859 @default.
• W2854404943 cites W1977475475 @default.
• W2854404943 cites W1977676160 @default.
• W2854404943 cites W1997533142 @default.
• W2854404943 cites W2005011993 @default.
• W2854404943 cites W2011826559 @default.
• W2854404943 cites W2013770585 @default.
• W2854404943 cites W2017055805 @default.
• W2854404943 cites W2020485312 @default.
• W2854404943 cites W2026634313 @default.
• W2854404943 cites W2027723397 @default.
• W2854404943 cites W2032072777 @default.
• W2854404943 cites W2034684595 @default.
• W2854404943 cites W2036090613 @default.
• W2854404943 cites W2043875683 @default.
• W2854404943 cites W2047440919 @default.
• W2854404943 cites W2061345986 @default.
• W2854404943 cites W2062115311 @default.
• W2854404943 cites W2065127180 @default.
• W2854404943 cites W2066001915 @default.
• W2854404943 cites W2070396671 @default.
• W2854404943 cites W2090296093 @default.
• W2854404943 cites W2100582497 @default.
• W2854404943 cites W2106721500 @default.
• W2854404943 cites W2116177733 @default.
• W2854404943 cites W2118814257 @default.
• W2854404943 cites W2125608170 @default.
• W2854404943 cites W2129308288 @default.
• W2854404943 cites W2140765540 @default.
• W2854404943 cites W2147213759 @default.
• W2854404943 cites W2149684379 @default.
• W2854404943 cites W2150489636 @default.
• W2854404943 cites W2150893994 @default.
• W2854404943 cites W2159573082 @default.
• W2854404943 cites W2169463345 @default.
• W2854404943 cites W2171962335 @default.
• W2854404943 cites W2172499884 @default.
• W2854404943 cites W2320943333 @default.
• W2854404943 cites W2403780458 @default.
• W2854404943 cites W2558455712 @default.
• W2854404943 cites W2594424275 @default.
• W2854404943 cites W2742246688 @default.
• W2854404943 cites W2745200809 @default.
• W2854404943 cites W2750728943 @default.
• W2854404943 cites W2803743594 @default.
• W2854404943 doi "https://doi.org/10.1016/j.antiviral.2018.07.005" @default.
• W2854404943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29981794" @default.
• W2854404943 hasPublicationYear "2018" @default.
• W2854404943 type Work @default.
• W2854404943 sameAs 2854404943 @default.
• W2854404943 citedByCount "35" @default.
• W2854404943 countsByYear W28544049432018 @default.
• W2854404943 countsByYear W28544049432019 @default.
• W2854404943 countsByYear W28544049432020 @default.
• W2854404943 countsByYear W28544049432021 @default.
• W2854404943 countsByYear W28544049432022 @default.
• W2854404943 countsByYear W28544049432023 @default.
• W2854404943 crossrefType "journal-article" @default.
• W2854404943 hasAuthorship W2854404943A5002035180 @default.
• W2854404943 hasAuthorship W2854404943A5003932349 @default.
• W2854404943 hasAuthorship W2854404943A5023118175 @default.
• W2854404943 hasAuthorship W2854404943A5051878224 @default.
• W2854404943 hasAuthorship W2854404943A5055970298 @default.
• W2854404943 hasAuthorship W2854404943A5078271785 @default.
• W2854404943 hasAuthorship W2854404943A5083661191 @default.
• W2854404943 hasAuthorship W2854404943A5085179199 @default.
• W2854404943 hasBestOaLocation W28544049431 @default.
• W2854404943 hasConcept C104317684 @default.
• W2854404943 hasConcept C140704245 @default.
• W2854404943 hasConcept C159047783 @default.
• W2854404943 hasConcept C2522874641 @default.
• W2854404943 hasConcept C2777062976 @default.
• W2854404943 hasConcept C2777343345 @default.
• W2854404943 hasConcept C2777474056 @default.
• W2854404943 hasConcept C2779755945 @default.
• W2854404943 hasConcept C2779756493 @default.

• next